Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-24
Pages: 80 Pages
Report ld: 6268528
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Antithrombogenic Heparin Coating Market Size(US$)
CAGR 2026-2032
9.2%
Market Size,2032
USD 306
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 181 million
Market Forecast in 2032(Value)
US$ 306 million
CAGR
9.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Antithrombogenic Heparin Coating market size was US$ 167 million in 2025 and is forecast to reach a readjusted size of US$ 306 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.
Antithrombogenic heparin coating refers to a layer of heparin that is applied to the surface of medical devices. Heparin is a glycosaminoglycan with a high negative charge density. It is a natural anticoagulant substance that can prevent blood from clotting. The heparin used in coatings usually has a certain purity and molecular weight range to ensure its anticoagulant effect.
In 2025, the North America Antithrombogenic Heparin Coating market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Antithrombogenic Heparin Coating include Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Antithrombogenic Heparin Coating market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
By Company
- Carmeda AB (Gore)
- Biointeractions
- Medtronic
- Surmodics
- Corline
- Toyobo
- jMedtech
- Biosurf
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Covalently Bonded Coatings
- Physisorption Coatings
Segment by Application
- Catheters
- Stents
- Implants
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Antithrombogenic Heparin Coating sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Antithrombogenic Heparin Coating manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Antithrombogenic Heparin Coating product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Antithrombogenic Heparin Coating value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Antithrombogenic Heparin Coating Product Scope
1.2 Antithrombogenic Heparin Coating by Type
1.2.1 Global Antithrombogenic Heparin Coating Sales by Type (2021, 2025 & 2032)
1.2.2 Covalently Bonded Coatings
1.2.3 Physisorption Coatings
1.3 Antithrombogenic Heparin Coating by Application
1.3.1 Global Antithrombogenic Heparin Coating Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Catheters
1.3.3 Stents
1.3.4 Implants
1.3.5 Others
1.4 Global Antithrombogenic Heparin Coating Market Estimates and Forecasts (2021-2032)
1.4.1 Global Antithrombogenic Heparin Coating Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Antithrombogenic Heparin Coating Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Antithrombogenic Heparin Coating Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Antithrombogenic Heparin Coating Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Antithrombogenic Heparin Coating Historical Market Scenario by Region (2021-2026)
2.2.1 Global Antithrombogenic Heparin Coating Sales Market Share by Region (2021-2026)
2.2.2 Global Antithrombogenic Heparin Coating Revenue Market Share by Region (2021-2026)
2.3 Global Antithrombogenic Heparin Coating Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Antithrombogenic Heparin Coating Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Antithrombogenic Heparin Coating Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Antithrombogenic Heparin Coating Market Size and Prospects (2021-2032)
2.4.2 Europe Antithrombogenic Heparin Coating Market Size and Prospects (2021-2032)
2.4.3 China Antithrombogenic Heparin Coating Market Size and Prospects (2021-2032)
2.4.4 Japan Antithrombogenic Heparin Coating Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Antithrombogenic Heparin Coating Historical Market Review by Type (2021-2026)
3.1.1 Global Antithrombogenic Heparin Coating Sales by Type (2021-2026)
3.1.2 Global Antithrombogenic Heparin Coating Revenue by Type (2021-2026)
3.1.3 Global Antithrombogenic Heparin Coating Average Price by Type (2021-2026)
3.2 Global Antithrombogenic Heparin Coating Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Antithrombogenic Heparin Coating Sales Forecast by Type (2027-2032)
3.2.2 Global Antithrombogenic Heparin Coating Revenue Forecast by Type (2027-2032)
3.2.3 Global Antithrombogenic Heparin Coating Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Antithrombogenic Heparin Coating
4 Global Market Size by Application
4.1 Global Antithrombogenic Heparin Coating Historical Market Review by Application (2021-2026)
4.1.1 Global Antithrombogenic Heparin Coating Sales by Application (2021-2026)
4.1.2 Global Antithrombogenic Heparin Coating Revenue by Application (2021-2026)
4.1.3 Global Antithrombogenic Heparin Coating Average Price by Application (2021-2026)
4.2 Global Antithrombogenic Heparin Coating Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Antithrombogenic Heparin Coating Sales Forecast by Application (2027-2032)
4.2.2 Global Antithrombogenic Heparin Coating Revenue Forecast by Application (2027-2032)
4.2.3 Global Antithrombogenic Heparin Coating Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Antithrombogenic Heparin Coating Applications
5 Competition Landscape by Players
5.1 Global Antithrombogenic Heparin Coating Sales by Player (2021-2026)
5.2 Global Top Antithrombogenic Heparin Coating Players by Revenue (2021-2026)
5.3 Global Antithrombogenic Heparin Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Antithrombogenic Heparin Coating revenue as of 2025
5.4 Global Antithrombogenic Heparin Coating Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Antithrombogenic Heparin Coating, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Antithrombogenic Heparin Coating, Product Type & Application
5.7 Global Key Manufacturers of Antithrombogenic Heparin Coating, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Antithrombogenic Heparin Coating Sales by Company
6.1.1.1 North America Antithrombogenic Heparin Coating Sales by Company (2021-2026)
6.1.1.2 North America Antithrombogenic Heparin Coating Revenue by Company (2021-2026)
6.1.2 North America Antithrombogenic Heparin Coating Sales Breakdown by Type (2021-2026)
6.1.3 North America Antithrombogenic Heparin Coating Sales Breakdown by Application (2021-2026)
6.1.4 North America Antithrombogenic Heparin Coating Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Antithrombogenic Heparin Coating Sales by Company
6.2.1.1 Europe Antithrombogenic Heparin Coating Sales by Company (2021-2026)
6.2.1.2 Europe Antithrombogenic Heparin Coating Revenue by Company (2021-2026)
6.2.2 Europe Antithrombogenic Heparin Coating Sales Breakdown by Type (2021-2026)
6.2.3 Europe Antithrombogenic Heparin Coating Sales Breakdown by Application (2021-2026)
6.2.4 Europe Antithrombogenic Heparin Coating Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Antithrombogenic Heparin Coating Sales by Company
6.3.1.1 China Antithrombogenic Heparin Coating Sales by Company (2021-2026)
6.3.1.2 China Antithrombogenic Heparin Coating Revenue by Company (2021-2026)
6.3.2 China Antithrombogenic Heparin Coating Sales Breakdown by Type (2021-2026)
6.3.3 China Antithrombogenic Heparin Coating Sales Breakdown by Application (2021-2026)
6.3.4 China Antithrombogenic Heparin Coating Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Antithrombogenic Heparin Coating Sales by Company
6.4.1.1 Japan Antithrombogenic Heparin Coating Sales by Company (2021-2026)
6.4.1.2 Japan Antithrombogenic Heparin Coating Revenue by Company (2021-2026)
6.4.2 Japan Antithrombogenic Heparin Coating Sales Breakdown by Type (2021-2026)
6.4.3 Japan Antithrombogenic Heparin Coating Sales Breakdown by Application (2021-2026)
6.4.4 Japan Antithrombogenic Heparin Coating Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Carmeda AB (Gore)
7.1.1 Carmeda AB (Gore) Company Information
7.1.2 Carmeda AB (Gore) Business Overview
7.1.3 Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Carmeda AB (Gore) Antithrombogenic Heparin Coating Products Offered
7.1.5 Carmeda AB (Gore) Recent Development
7.2 Biointeractions
7.2.1 Biointeractions Company Information
7.2.2 Biointeractions Business Overview
7.2.3 Biointeractions Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Biointeractions Antithrombogenic Heparin Coating Products Offered
7.2.5 Biointeractions Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Medtronic Antithrombogenic Heparin Coating Products Offered
7.3.5 Medtronic Recent Development
7.4 Surmodics
7.4.1 Surmodics Company Information
7.4.2 Surmodics Business Overview
7.4.3 Surmodics Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Surmodics Antithrombogenic Heparin Coating Products Offered
7.4.5 Surmodics Recent Development
7.5 Corline
7.5.1 Corline Company Information
7.5.2 Corline Business Overview
7.5.3 Corline Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Corline Antithrombogenic Heparin Coating Products Offered
7.5.5 Corline Recent Development
7.6 Toyobo
7.6.1 Toyobo Company Information
7.6.2 Toyobo Business Overview
7.6.3 Toyobo Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Toyobo Antithrombogenic Heparin Coating Products Offered
7.6.5 Toyobo Recent Development
7.7 jMedtech
7.7.1 jMedtech Company Information
7.7.2 jMedtech Business Overview
7.7.3 jMedtech Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2021-2026)
7.7.4 jMedtech Antithrombogenic Heparin Coating Products Offered
7.7.5 jMedtech Recent Development
7.8 Biosurf
7.8.1 Biosurf Company Information
7.8.2 Biosurf Business Overview
7.8.3 Biosurf Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Biosurf Antithrombogenic Heparin Coating Products Offered
7.8.5 Biosurf Recent Development
8 Antithrombogenic Heparin Coating Manufacturing Cost Analysis
8.1 Antithrombogenic Heparin Coating Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Antithrombogenic Heparin Coating
8.4 Antithrombogenic Heparin Coating Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Antithrombogenic Heparin Coating Distributors List
9.3 Antithrombogenic Heparin Coating Customers
10 Antithrombogenic Heparin Coating Market Dynamics
10.1 Antithrombogenic Heparin Coating Industry Trends
10.2 Antithrombogenic Heparin Coating Market Drivers
10.3 Antithrombogenic Heparin Coating Market Challenges
10.4 Antithrombogenic Heparin Coating Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Antithrombogenic Heparin Coating Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Antithrombogenic Heparin Coating Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Antithrombogenic Heparin Coating Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Antithrombogenic Heparin Coating Sales (Tons) by Region (2021-2026)
Table 5. Global Antithrombogenic Heparin Coating Sales Market Share by Region (2021-2026)
Table 6. Global Antithrombogenic Heparin Coating Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Antithrombogenic Heparin Coating Revenue Share by Region (2021-2026)
Table 8. Global Antithrombogenic Heparin Coating Sales (Tons) Forecast by Region (2027-2032)
Table 9. Global Antithrombogenic Heparin Coating Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Antithrombogenic Heparin Coating Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Antithrombogenic Heparin Coating Revenue Share Forecast by Region (2027-2032)
Table 12. Global Antithrombogenic Heparin Coating Sales by Type (Tons) & (2021-2026)
Table 13. Global Antithrombogenic Heparin Coating Sales Share by Type (2021-2026)
Table 14. Global Antithrombogenic Heparin Coating Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Antithrombogenic Heparin Coating Average Price by Type (US$/Kg) & (2021-2026)
Table 16. Global Antithrombogenic Heparin Coating Sales by Type (Tons) & (2027-2032)
Table 17. Global Antithrombogenic Heparin Coating Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Antithrombogenic Heparin Coating Average Price by Type (US$/Kg) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Antithrombogenic Heparin Coating Sales by Application (Tons) & (2021-2026)
Table 21. Global Antithrombogenic Heparin Coating Sales Share by Application (2021-2026)
Table 22. Global Antithrombogenic Heparin Coating Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Antithrombogenic Heparin Coating Average Price by Application (US$/Kg) & (2021-2026)
Table 24. Global Antithrombogenic Heparin Coating Sales by Application (Tons) & (2027-2032)
Table 25. Global Antithrombogenic Heparin Coating Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Antithrombogenic Heparin Coating Average Price by Application (US$/Kg) & (2027-2032)
Table 27. New Sources of Growth in Antithrombogenic Heparin Coating Applications
Table 28. Global Antithrombogenic Heparin Coating Sales by Company (Tons) & (2021-2026)
Table 29. Global Antithrombogenic Heparin Coating Sales Share by Company (2021-2026)
Table 30. Global Antithrombogenic Heparin Coating Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Antithrombogenic Heparin Coating Revenue Share by Company (2021-2026)
Table 32. Global Antithrombogenic Heparin Coating by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombogenic Heparin Coating as of 2025)
Table 33. Global Market Antithrombogenic Heparin Coating Average Price by Company (US$/Kg) & (2021-2026)
Table 34. Global Key Manufacturers of Antithrombogenic Heparin Coating, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Antithrombogenic Heparin Coating, Product Type & Application
Table 36. Global Key Manufacturers of Antithrombogenic Heparin Coating, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Antithrombogenic Heparin Coating Sales by Company (2021-2026) & (Tons)
Table 39. North America Antithrombogenic Heparin Coating Sales Market Share by Company (2021-2026)
Table 40. North America Antithrombogenic Heparin Coating Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Antithrombogenic Heparin Coating Revenue Market Share by Company (2021-2026)
Table 42. North America Antithrombogenic Heparin Coating Sales by Type (2021-2026) & (Tons)
Table 43. North America Antithrombogenic Heparin Coating Sales Market Share by Type (2021-2026)
Table 44. North America Antithrombogenic Heparin Coating Sales by Application (2021-2026) & (Tons)
Table 45. North America Antithrombogenic Heparin Coating Sales Market Share by Application (2021-2026)
Table 46. Europe Antithrombogenic Heparin Coating Sales by Company (2021-2026) & (Tons)
Table 47. Europe Antithrombogenic Heparin Coating Sales Market Share by Company (2021-2026)
Table 48. Europe Antithrombogenic Heparin Coating Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Antithrombogenic Heparin Coating Revenue Market Share by Company (2021-2026)
Table 50. Europe Antithrombogenic Heparin Coating Sales by Type (2021-2026) & (Tons)
Table 51. Europe Antithrombogenic Heparin Coating Sales Market Share by Type (2021-2026)
Table 52. Europe Antithrombogenic Heparin Coating Sales by Application (2021-2026) & (Tons)
Table 53. Europe Antithrombogenic Heparin Coating Sales Market Share by Application (2021-2026)
Table 54. China Antithrombogenic Heparin Coating Sales by Company (2021-2026) & (Tons)
Table 55. China Antithrombogenic Heparin Coating Sales Market Share by Company (2021-2026)
Table 56. China Antithrombogenic Heparin Coating Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Antithrombogenic Heparin Coating Revenue Market Share by Company (2021-2026)
Table 58. China Antithrombogenic Heparin Coating Sales by Type (2021-2026) & (Tons)
Table 59. China Antithrombogenic Heparin Coating Sales Market Share by Type (2021-2026)
Table 60. China Antithrombogenic Heparin Coating Sales by Application (2021-2026) & (Tons)
Table 61. China Antithrombogenic Heparin Coating Sales Market Share by Application (2021-2026)
Table 62. Japan Antithrombogenic Heparin Coating Sales by Company (2021-2026) & (Tons)
Table 63. Japan Antithrombogenic Heparin Coating Sales Market Share by Company (2021-2026)
Table 64. Japan Antithrombogenic Heparin Coating Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Antithrombogenic Heparin Coating Revenue Market Share by Company (2021-2026)
Table 66. Japan Antithrombogenic Heparin Coating Sales by Type (2021-2026) & (Tons)
Table 67. Japan Antithrombogenic Heparin Coating Sales Market Share by Type (2021-2026)
Table 68. Japan Antithrombogenic Heparin Coating Sales by Application (2021-2026) & (Tons)
Table 69. Japan Antithrombogenic Heparin Coating Sales Market Share by Application (2021-2026)
Table 70. Carmeda AB (Gore) Company Information
Table 71. Carmeda AB (Gore) Description and Business Overview
Table 72. Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 73. Carmeda AB (Gore) Antithrombogenic Heparin Coating Product
Table 74. Carmeda AB (Gore) Recent Development
Table 75. Biointeractions Company Information
Table 76. Biointeractions Description and Business Overview
Table 77. Biointeractions Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 78. Biointeractions Antithrombogenic Heparin Coating Product
Table 79. Biointeractions Recent Development
Table 80. Medtronic Company Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 83. Medtronic Antithrombogenic Heparin Coating Product
Table 84. Medtronic Recent Development
Table 85. Surmodics Company Information
Table 86. Surmodics Description and Business Overview
Table 87. Surmodics Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 88. Surmodics Antithrombogenic Heparin Coating Product
Table 89. Surmodics Recent Development
Table 90. Corline Company Information
Table 91. Corline Description and Business Overview
Table 92. Corline Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 93. Corline Antithrombogenic Heparin Coating Product
Table 94. Corline Recent Development
Table 95. Toyobo Company Information
Table 96. Toyobo Description and Business Overview
Table 97. Toyobo Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 98. Toyobo Antithrombogenic Heparin Coating Product
Table 99. Toyobo Recent Development
Table 100. jMedtech Company Information
Table 101. jMedtech Description and Business Overview
Table 102. jMedtech Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 103. jMedtech Antithrombogenic Heparin Coating Product
Table 104. jMedtech Recent Development
Table 105. Biosurf Company Information
Table 106. Biosurf Description and Business Overview
Table 107. Biosurf Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026)
Table 108. Biosurf Antithrombogenic Heparin Coating Product
Table 109. Biosurf Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Antithrombogenic Heparin Coating Distributors List
Table 113. Antithrombogenic Heparin Coating Customers List
Table 114. Antithrombogenic Heparin Coating Market Trends
Table 115. Antithrombogenic Heparin Coating Market Drivers
Table 116. Antithrombogenic Heparin Coating Market Challenges
Table 117. Antithrombogenic Heparin Coating Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Antithrombogenic Heparin Coating Product Picture
Figure 2. Global Antithrombogenic Heparin Coating Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Antithrombogenic Heparin Coating Sales Market Share by Type in 2025 & 2032
Figure 4. Covalently Bonded Coatings Product Picture
Figure 5. Physisorption Coatings Product Picture
Figure 6. Global Antithrombogenic Heparin Coating Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 7. Global Antithrombogenic Heparin Coating Sales Market Share by Application in 2025 & 2032
Figure 8. Catheters Examples
Figure 9. Stents Examples
Figure 10. Implants Examples
Figure 11. Others Examples
Figure 12. Global Antithrombogenic Heparin Coating Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 13. Global Antithrombogenic Heparin Coating Sales Growth Rate (2021-2032) & (US$ Million)
Figure 14. Global Antithrombogenic Heparin Coating Sales (Tons) Growth Rate (2021-2032)
Figure 15. Global Antithrombogenic Heparin Coating Price Trends Growth Rate (2021-2032) & (US$/Kg)
Figure 16. Antithrombogenic Heparin Coating Report Years Considered
Figure 17. Global Market Antithrombogenic Heparin Coating Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 18. Global Antithrombogenic Heparin Coating Revenue Market Share by Region: 2021 VS 2025
Figure 19. North America Antithrombogenic Heparin Coating Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. North America Antithrombogenic Heparin Coating Sales (Tons) Growth Rate (2021-2032)
Figure 21. Europe Antithrombogenic Heparin Coating Revenue (US$ Million) Growth Rate (2021-2032)
Figure 22. Europe Antithrombogenic Heparin Coating Sales (Tons) Growth Rate (2021-2032)
Figure 23. China Antithrombogenic Heparin Coating Revenue (US$ Million) Growth Rate (2021-2032)
Figure 24. China Antithrombogenic Heparin Coating Sales (Tons) Growth Rate (2021-2032)
Figure 25. Japan Antithrombogenic Heparin Coating Revenue (US$ Million) Growth Rate (2021-2032)
Figure 26. Japan Antithrombogenic Heparin Coating Sales (Tons) Growth Rate (2021-2032)
Figure 27. Global Antithrombogenic Heparin Coating Revenue Share by Type (2021-2026)
Figure 28. Global Antithrombogenic Heparin Coating Sales Share by Type (2027-2032)
Figure 29. Global Antithrombogenic Heparin Coating Revenue Share by Type (2027-2032)
Figure 30. Global Antithrombogenic Heparin Coating Revenue Share by Application (2021-2026)
Figure 31. Global Antithrombogenic Heparin Coating Revenue Market Share by Application in 2021 & 2025
Figure 32. Global Antithrombogenic Heparin Coating Sales Share by Application (2027-2032)
Figure 33. Global Antithrombogenic Heparin Coating Revenue Share by Application (2027-2032)
Figure 34. Global Antithrombogenic Heparin Coating Sales Share by Company (2025)
Figure 35. Global Antithrombogenic Heparin Coating Revenue Share by Company (2025)
Figure 36. Global 5 Largest Antithrombogenic Heparin Coating Players Market Share by Revenue in Antithrombogenic Heparin Coating: 2021 & 2025
Figure 37. Antithrombogenic Heparin Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 38. Manufacturing Cost Structure of Antithrombogenic Heparin Coating
Figure 39. Manufacturing Process Analysis of Antithrombogenic Heparin Coating
Figure 40. Antithrombogenic Heparin Coating Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Antithrombogenic Heparin Coating in 2026?
The global market size of Antithrombogenic Heparin Coating in 2026 was 181 Million USD.
Which region is expected to have the highest market share?
What was the global market size of Antithrombogenic Heparin Coating in 2032?
Which companies rank high in the global Antithrombogenic Heparin Coating market?
What is the annual compound growth rate of the global Antithrombogenic Heparin Coating market size from 2026 to 2032?
Related Reports
Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 167 million in 2025 to US$ 306 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 150
USD 4900.00
(Single User License)
Antithrombogenic Heparin Coating- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 167 million in 2025 and is projected to reach US$ 306 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 107
USD 3950.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Research Report 2026
The global Antithrombogenic Heparin Coating market was valued at US$ 167 million in 2025 and is anticipated to reach US$ 306 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 114
USD 2900.00
(Single User License)
Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antithrombogenic Heparin Coating market size was US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 79
USD 4250.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 154 million in 2024 to US$ 283 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 148
USD 4900.00
(Single User License)
Antithrombogenic Heparin Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 96
USD 3950.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Research Report 2025
The global market for Antithrombogenic Heparin Coating was valued at US$ 154 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Research Report 2024
The global market for Antithrombogenic Heparin Coating was valued at US$ 142 million in the year 2023 and is projected to reach a revised size of US$ 261 million by 2030, growing at a CAGR of 9.2% during the forecast period.
Published Date: 2024-12-15
Pages: 86
USD 2900.00
(Single User License)
Global and United States Antithrombogenic Heparin Coating Market Report & Forecast 2024-2030
The global Antithrombogenic Heparin Coating revenue was US$ 142 million in 2023 and is forecast to a readjusted size of US$ 261 million by 2030 with a CAGR of 9.2% during the review period (2024-2030).
Published Date: 2024-12-15
Pages: 119
USD 4350.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Insights, Forecast to 2030
Valued at US$ 154 million in 2024, the global Antithrombogenic Heparin Coating market is forecast to reach US$ 261 million by 2030, at a CAGR of 9.2% during the forecast period.
Published Date: 2024-12-15
Pages: 135
USD 4900.00
(Single User License)
Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 167 million in 2025 to US$ 306 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 150
USD 4900.00 (Single User License)Antithrombogenic Heparin Coating- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 167 million in 2025 and is projected to reach US$ 306 million, growing at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-19
Pages: 107
USD 3950.00 (Single User License)Global Antithrombogenic Heparin Coating Market Research Report 2026
The global Antithrombogenic Heparin Coating market was valued at US$ 167 million in 2025 and is anticipated to reach US$ 306 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 114
USD 2900.00 (Single User License)Global Antithrombogenic Heparin Coating Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Antithrombogenic Heparin Coating market size was US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 79
USD 4250.00 (Single User License)Global Antithrombogenic Heparin Coating Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Antithrombogenic Heparin Coating market is projected to grow from US$ 154 million in 2024 to US$ 283 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 148
USD 4900.00 (Single User License)Antithrombogenic Heparin Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Antithrombogenic Heparin Coating was estimated to be worth US$ 154 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 96
USD 3950.00 (Single User License)Global Antithrombogenic Heparin Coating Market Research Report 2025
The global market for Antithrombogenic Heparin Coating was valued at US$ 154 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 9.2% during the forecast period.
Published: 2025-03-10
Pages: 87
USD 2900.00 (Single User License)Global Antithrombogenic Heparin Coating Market Research Report 2024
The global market for Antithrombogenic Heparin Coating was valued at US$ 142 million in the year 2023 and is projected to reach a revised size of US$ 261 million by 2030, growing at a CAGR of 9.2% during the forecast period.
Published: 2024-12-15
Pages: 86
USD 2900.00 (Single User License)Global and United States Antithrombogenic Heparin Coating Market Report & Forecast 2024-2030
The global Antithrombogenic Heparin Coating revenue was US$ 142 million in 2023 and is forecast to a readjusted size of US$ 261 million by 2030 with a CAGR of 9.2% during the review period (2024-2030).
Published: 2024-12-15
Pages: 119
USD 4350.00 (Single User License)Global Antithrombogenic Heparin Coating Market Insights, Forecast to 2030
Valued at US$ 154 million in 2024, the global Antithrombogenic Heparin Coating market is forecast to reach US$ 261 million by 2030, at a CAGR of 9.2% during the forecast period.
Published: 2024-12-15
Pages: 135
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now